Silihan lan utang jangka dawa perusahaan: Avinger Inc. (AVGR)

Tandha merek Avinger Inc (AVGR)

The market valuation chart for Avinger, Inc. (AVGR) reflects the dynamics of debt obligations, which currently stand at 0.00. Proprietary copyrights for diagnostic systems serve as a business safeguard, although their effectiveness is declining due to pressure from industry behemoths. Avinger, Inc. (AVGR) generates revenue through the sale of disposable catheters and devices for minimally invasive surgeries. While management possesses deep technical expertise, they are facing challenges in expanding their market presence.

AVGR Avinger Inc: Utang jangka dawa perusahaan ing interval 04.07.2022 - 22.02.2025
Produk asil prodhuksi Avinger, Inc

Long-term debt measures the total volume of obligations with a maturity of more than one year, reflecting the external financing strategy. For Avinger, Inc. (AVGR), this capital is critical when scaling the production of patented OCT catheters. An analysis of the firm's long-term borrowings allows for an assessment of the balance between technology investments and debt load. An increase in loans may signal default risk, while a decrease may indicate stagnation. This indicator determines the stability of the issuer's investment profile.

Karo sapa Avinger, Inc. saingan

dexcom.com (DXCM) - Utang jangka dawa|PEN - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan NOVT (Novanta Inc)|HAE: Utang jangka dawa perusahaan|Inspire Medical Systems Inc (INSP) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan PROCEPT BioRobotics|conmed.com - Kewajiban jangka dawa|Utang jangka dawa perusahaan PLSE|INMD - Utang jangka dawa|Picard Medical Inc. - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan Surmodics Inc. SRDX|SENS: Kewajiban jangka dawa perusahaan|neuropace.com - Gedhene kewajiban jangka dawa|TCMD: Utang jangka dawa perusahaan|SNWV - Gunggunge utang jangka dawa|OM (Outset) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Electromed Inc (ELMD)|Kewajiban jangka dawa perusahaan LNSR (LENSAR, Inc.)|RCEL (avitamedical.com) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Profound Medical PROF|BDMD - Kewajiban jangka dawa perusahaan|EDAP Medical - Utang jangka dawa perusahaan|Utang jangka dawa Apyx Medical|ICCM: Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan LUNG|TELA (TELA Bio Inc.) - Utang jangka dawa perusahaan|CytoSorbents Corp. (CTSO) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan SRTS|Kewajiban jangka dawa perusahaan Zynex Corp ZYXI|Utang jangka dawa perusahaan ECOR (electroCore)|Utang jangka dawa perusahaan Vicarious Surgical Inc RBOT|IINN - Utang jangka dawa perusahaan|ICU: Utang jangka dawa perusahaan|IRIX (iridex.com) - Kewajiban jangka dawa perusahaan|Intelligent Bio Solutions Inc. - Silihan lan utang jangka dawa perusahaan|XAIR (Beyond Air Inc) - Utang jangka dawa perusahaan|Utang jangka dawa profusa.com PFSA|Utang jangka dawa perusahaan STRATA Skin Sciences (SSKN)|GlucoTrack Inc. (GCTK) - Tanggungan jangka dawa|NanoVibronix, Inc. - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan Venus Concept Corporation VERO|Nuwellis, Inc. - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa aethlonmedical.com AEMD|asensus.com (ASXC) - Utang jangka dawa perusahaan|Kewajiban jangka dawa BSGM (biosig.com)|Utang jangka dawa perusahaan Cutera, Inc|Kewajiban jangka dawa perusahaan Know Labs Corporation (KNW)|Utang jangka dawa perusahaan NARI|NVRO - Utang jangka dawa|Utang jangka dawa perusahaan ReShape Lifesciences Inc. RSLS|SILK: Tanggungan utang jangka dawa perusahaan